80.96
0.32 (0.40%)
| Previous Close | 80.64 |
| Open | 81.79 |
| Volume | 2,649,055 |
| Avg. Volume (3M) | 3,530,483 |
| Market Cap | 12,584,502,272 |
| Price / Sales | 2.32 |
| Price / Book | 2.39 |
| 52 Weeks Range | |
| Earnings Date | 13 Aug 2025 - 18 Aug 2025 |
| Profit Margin | 1.72% |
| Operating Margin (TTM) | 9.71% |
| Diluted EPS (TTM) | -0.220 |
| Quarterly Revenue Growth (YOY) | 23.90% |
| Total Debt/Equity (MRQ) | 48.29% |
| Current Ratio (MRQ) | 2.47 |
| Operating Cash Flow (TTM) | 665.64 M |
| Levered Free Cash Flow (TTM) | 530.34 M |
| Return on Assets (TTM) | 2.02% |
| Return on Equity (TTM) | 1.00% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bearish | Mixed |
| Scientific & Technical Instruments (Global) | Bearish | Mixed | |
| Stock | Coherent Corp. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | -2.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.70 |
|
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Mid Growth |
| % Held by Insiders | 1.14% |
| % Held by Institutions | 94.44% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Sachem Head Capital Management Lp | 31 Mar 2025 | 2,775,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 115.00 (Citigroup, 42.05%) | Buy |
| Median | 95.00 (17.34%) | |
| Low | 80.00 (Barclays, -1.19%) | Buy |
| Average | 94.00 (16.11%) | |
| Total | 6 Buy, 1 Hold | |
| Avg. Price @ Call | 75.10 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 12 Jun 2025 | 100.00 (23.52%) | Buy | 80.95 |
| 17 Apr 2025 | 80.00 (-1.19%) | Buy | 55.29 | |
| Citigroup | 03 Jun 2025 | 115.00 (42.05%) | Buy | 80.50 |
| 14 Apr 2025 | 110.00 (35.87%) | Buy | 56.14 | |
| Morgan Stanley | 29 May 2025 | 83.00 (2.52%) | Hold | 79.52 |
| 23 May 2025 | 74.00 (-8.60%) | Hold | 78.46 | |
| Needham | 29 May 2025 | 90.00 (11.17%) | Buy | 79.52 |
| 28 Apr 2025 | 85.00 (4.99%) | Buy | 64.81 | |
| Rosenblatt | 29 May 2025 | 95.00 (17.34%) | Buy | 79.52 |
| 08 May 2025 | 95.00 (17.34%) | Buy | 70.59 | |
| Benchmark | 08 May 2025 | 95.00 (17.34%) | Buy | 70.59 |
| Barclays | 22 Apr 2025 | 80.00 (-1.19%) | Buy | 55.13 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Jun 2025 | Announcement | Coherent to Showcase Innovative Products, Technologies, and Thought Leadership at Laser World of Photonics 2025 |
| 24 Jun 2025 | Announcement | Coherent Launches ACE FL, an All-New, Two-Micron Fiber Laser to Address the Expanding Opportunities in Urology and Other Medical Markets |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |